Table 1 –
Cell Type | Cell Source | Culture Media |
---|---|---|
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) | Differentiated from monolayers of human iPSCs using small molecule modulation of the Wnt pathway [24]. Purified using metabolic selection [25]. |
Days 0–7 days of culture: RPMI-1640, 2% B-27 supplement, 2 mg/mL aminocaproic acid, 50 ug/mL ascorbic acid 2-phosphate, 1% penicillin-streptomycin, 1% non-essential amino acids, 1% sodium pyruvate, 0.45μM 1-thioglycerol Days 7–21 of culture: Low-glucose DMEM, 5% fetal bovine serum, 2 mg/mL aminocaproic acid, 50 ug/mL ascorbic acid 2-phosphate, 1% penicillin-streptomycin, 1% non-essential amino acids, 0.45μM 1-thioglycerol [2] |
Human embryonic stem cell-derived cardiomyocytes (hESC-CMs) | Differentiated from embryoid bodies of human ESCs using previously published protocols [26]. Purified using magnetic-activated cell sorting for SIRPA-positive cells [26]. | DMEM, 5% fetal bovine serum, 1 mg/mL aminocaproic acid, 50 μg/mL ascorbic acid 2-phosphate, 1 mM sodium pyruvate, 2 mM glutamine, 0.1 mM non-essential amino acids, 0.45 mM 1-thioglycerol [20] |
Neonatal rat ventricular myocytes (NRVMs) | Enzymatically digested from the ventricles of 2-day-old Sprague Dawley rats. Purified using two pre-plating steps [11]. | Low-glucose DMEM, 10% horse serum, 1% chick embryo extract, 1 mg/mL aminocaproic acid, 50 μg/mL ascorbic acid 2-phosphate, 5 U/mL penicillin, 2 μg/mL vitamin B-12 [19] |
Mouse induced pluripotent stem cell-derived cardiovascular progenitors (miPSC-CVPs) | Differentiated from embryoid bodies of mouse iPSCs using published methods [22]. miPSCs stably transfected with puromycin N-acetyl transferase under the control of a Nkx2–5 cardiac-specific enhancer element to allow for purification of progenitor cells by puromycin selection [22]. | 1:1 ratio of DMEM/F12 and Neurobasal base medium, 1x N2 supplement, 1x B-27 supplement, Glutamax-I, non-essential amino acids, β-Mercaptoethanol, 5 mg/mL BSA, Gentamicin, 1 mg/mL aminocaproic acid [22] |
Mouse embryonic stem cell-derived cardiomyocytes and cardiovascular progenitors (mESC-CMs and mESC-CVPs) | Differentiated from embryoid bodies of mouse ESCs using published protocols [21,27]. mESCs stably transfected with puromycin aminotransferase under the control of a mouse Myh6 promotor or a Nkx2.5 enhancer element to allow for purification by puromycin selection [21]. | 1:1 ratio of DMEM/F12 and Neurobasal base medium, 1% L-glutamine, 0.1% gentamicin reagent solution, 1% B-27 supplement, 0.0125 mg/mL insulin, 0.05 mg/mL apo-transferrin, 2.5 ng/mL sodium selenite, 3 ng/mL progesterone, 8 ug/mL putrescine, 0.0334% BSA fraction V, 1 mg/mL aminocaproic acid [21] |